600161 (600161) News
Follow 600161 (600161) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Beijing Tiantan Biological Products H1 profit down 52.75% Y/Y
Beijing Tiantan Biological Products reported H1 net profit down 52.75% year-over-year.
EQUITY | Aug 28, 2026, 09:25 AM UTC
M
Beijing Tiantan Biological Products revenue and profit fall over 50% YoY
Beijing Tiantan Biological Products reported revenue and profit down over 50% year-over-year, citing industry headwinds and policy changes.
EQUITY | Aug 28, 2026, 09:24 AM UTC